Connecting you to content on EBSCOhost

Works matching IS 17588340 AND DT 2009 AND VI 1 AND IP 3

Results: 6

1

Acknowledgements.

Published in:: Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 207, doi. 10.1177/1758834009353357
Publication type:: Article

2

Review: Targeted therapy in renal cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 183, doi. 10.1177/1758834009349119

By:

Dorff, Tanya B.;
Goldkorn, Amir;
Quinn, David I.

Publication type:

Article

3

Review: Beyond KRAS: perspectives on new potential markers of intrinsic and acquired resistance to epidermal growth factor receptor inhibitors in metastatic colorectal cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 167, doi. 10.1177/1758834009348984

By:

Loupakis, Fotios;
Cremolini, Chiara;
Fontanini, Gabriella;
Stasi, Irene;
Salvatore, Lisa;
Falcone, Alfredo

Publication type:

Article

4

Review: Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 137, doi. 10.1177/1758834009347923

By:

Peled, Nir;
Yoshida, Koichi;
Wynes, Murry W.;
Hirsch, Fred R.

Publication type:

Article

5

Review: Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers.

Published in:

Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 145, doi. 10.1177/1758834009347323

By:

Power, D.G.;
Ilson, D.H.

Publication type:

Article

6

Review: Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?

Published in:

Therapeutic Advances in Medical Oncology, 2009, v. 1, n. 3, p. 123, doi. 10.1177/1758834009344594

By:

Gnant, Michael;
Blaha, Peter;
Dubsky, Peter;
Exner, Ruth;
Fitzal, Florian;
Sporn, Emanuel;
Panhofer, Peter;
Dal Borgo, Andrea;
Bigenzahn, Sinda;
Steger, Guenther;
Jakesz, Raimund

Publication type:

Article